Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.73%190.5M | -8.62%830.1M | -6.06%192.2M | -8.21%210.3M | -7.23%214.2M | -12.47%213.4M | -6.47%908.4M | -8.55%204.6M | -7.33%229.1M | -8.36%230.9M |
Operating revenue | -10.73%190.5M | -8.62%830.1M | -6.06%192.2M | -8.21%210.3M | -7.23%214.2M | -12.47%213.4M | -6.47%908.4M | -8.55%204.6M | -7.33%229.1M | -8.36%230.9M |
Cost of revenue | -8.06%133.5M | -8.03%553M | -4.88%130.5M | -8.41%136.2M | -6.74%141.1M | -11.52%145.2M | -7.52%601.3M | -10.16%137.2M | -12.10%148.7M | -8.55%151.3M |
Gross profit | -16.42%57M | -9.77%277.1M | -8.46%61.7M | -7.84%74.1M | -8.17%73.1M | -14.43%68.2M | -4.33%307.1M | -5.10%67.4M | 2.99%80.4M | -8.00%79.6M |
Operating expense | -8.87%51.4M | -4.56%228M | -6.90%58M | 2.11%53.2M | 10.83%60.4M | -19.08%56.4M | -6.46%238.9M | -4.82%62.3M | -12.87%52.1M | -15.09%54.5M |
Selling and administrative expenses | -6.32%44.5M | -4.82%193.4M | -4.22%49.9M | 1.81%45.1M | 9.70%50.9M | -20.97%47.5M | -7.72%203.2M | -6.47%52.1M | -12.54%44.3M | -17.35%46.4M |
-General and administrative expense | ---- | -4.82%193.4M | -4.22%49.9M | 1.81%45.1M | 9.70%50.9M | ---- | -7.72%203.2M | --52.1M | --44.3M | --46.4M |
Research and development costs | -20.22%7.1M | -3.08%34.6M | -20.59%8.1M | 3.85%8.1M | 17.28%9.5M | -7.29%8.9M | 1.42%35.7M | 4.62%10.2M | -14.66%7.8M | 0.62%8.1M |
Other operating expenses | ---200K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit | -52.54%5.6M | -28.01%49.1M | -27.45%3.7M | -26.15%20.9M | -49.40%12.7M | 18.00%11.8M | 3.96%68.2M | -8.44%5.1M | 54.89%28.3M | 12.40%25.1M |
Net non-operating interest income expense | 137.50%300K | 92.08%-800K | 113.33%200K | 0 | 92.86%-200K | 77.14%-800K | -6.32%-10.1M | 61.94%-1.5M | 21.82%-2.3M | -80.88%-2.8M |
Non-operating interest income | 700.00%800K | 16.67%1.4M | 200.00%600K | 150.00%500K | -33.33%200K | -80.00%100K | 71.43%1.2M | -15.97%200K | 8.11%200K | 67.60%300K |
Non-operating interest expense | -50.00%400K | -84.62%1.6M | -84.62%200K | -87.50%300K | -90.00%300K | -78.38%800K | 9.47%10.4M | -68.11%1.3M | -18.62%2.4M | 100.40%3M |
Total other finance cost | 0.00%100K | -33.33%600K | -50.00%200K | 100.00%200K | 0.00%100K | -66.67%100K | 28.57%900K | 292.16%400K | -43.82%100K | -56.52%100K |
Other net income (expense) | -1,350.00%-7.5M | -179.77%-13.8M | -126.56%-6.4M | -3,800.00%-7.4M | -123.08%-600K | 105.94%600K | -79.38%17.3M | -68.44%24.1M | -91.47%200K | -18.37%2.6M |
Gain on sale of security | -425.00%-1.3M | ---- | ---- | ---- | ---- | --400K | ---- | ---- | ---- | ---- |
Earnings from equity interest | --0 | -22.22%1.4M | -33.33%200K | -33.33%400K | -37.50%500K | 200.00%300K | -59.09%1.8M | 84.05%300K | -48.36%600K | -55.56%800K |
Special income (charges) | -5,800.00%-5.9M | -248.15%-24M | -166.12%-16.2M | -472.73%-6.3M | -153.85%-1.4M | 99.03%-100K | 125.43%16.2M | 137.44%24.5M | -636.59%-1.1M | 143.90%2.6M |
-Less:Restructuring and merger&acquisition | 5,800.00%5.9M | -4.14%16.2M | 1,580.00%8.4M | 215.00%6.3M | -64.10%1.4M | -99.05%100K | 1,026.67%16.9M | -15.68%500K | 436.19%2M | 738.71%3.9M |
-Less:Impairment of capital assets | ---- | --7.9M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | -1,170.83%-30.5M | -5,386.04%-23.1M | -20.48%-700K | -244.83%-6M |
-Write off | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | -96.15%100K | -94.74%100K | --0 | --0 | ---- | 420.00%2.6M | 291.75%1.9M | 6,766.67%200K | 16,566.67%500K |
Other non- operating income (expenses) | -175.00%-300K | 1,357.14%8.8M | --9.6M | -314.29%-1.5M | 137.50%300K | 300.00%400K | -100.49%-700K | ---- | -28.35%700K | -350.78%-800K |
Income before tax | -113.79%-1.6M | -55.05%34.3M | -109.44%-2.7M | -48.47%13.5M | -52.59%11.9M | 422.22%11.6M | -45.66%76.3M | -63.52%28.6M | 48.25%26.2M | 4.73%25.1M |
Income tax | -105.26%-200K | -58.38%8.2M | -140.74%-2.2M | -61.11%2.8M | -47.22%3.8M | 3,900.00%3.8M | -17.23%19.7M | -51.43%5.4M | 153.97%7.2M | 18.34%7.2M |
Net income | -117.95%-1.4M | -53.89%26.1M | -102.16%-500K | -43.68%10.7M | -54.75%8.1M | 322.86%7.8M | -51.46%56.6M | -65.52%23.2M | 28.05%19M | 0.10%17.9M |
Net income continuous Operations | -117.95%-1.4M | -53.89%26.1M | -102.16%-500K | -43.68%10.7M | -54.75%8.1M | 322.86%7.8M | -51.46%56.6M | -65.52%23.2M | 28.05%19M | 0.10%17.9M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -117.95%-1.4M | -53.89%26.1M | -102.16%-500K | -43.68%10.7M | -54.75%8.1M | 322.86%7.8M | -51.46%56.6M | -65.52%23.2M | 28.05%19M | 0.10%17.9M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -117.95%-1.4M | -53.89%26.1M | -102.16%-500K | -43.68%10.7M | -54.75%8.1M | 322.86%7.8M | -51.46%56.6M | -65.52%23.2M | 28.05%19M | 0.10%17.9M |
Basic earnings per share | -119.05%-0.08 | -53.95%1.4 | -102.40%-0.03 | -43.14%0.58 | -54.17%0.44 | 321.05%0.42 | -51.05%3.04 | -65.18%1.25 | 29.11%1.02 | 1.05%0.96 |
Diluted earnings per share | -119.05%-0.08 | -53.80%1.4 | -102.42%-0.03 | -43.14%0.58 | -54.17%0.44 | 321.05%0.42 | -50.73%3.03 | -65.36%1.24 | 30.77%1.02 | 2.13%0.96 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |